CTRI/2018/04/013249CompletedPhase 2
A Clinical study to evaluate the safety and efficacy of GastriCare in individuals with Functional Dyspepsia
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- The Himalaya Drug Company
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1 Subjects of both sexes in the age group of 18 - 60 years, with gastric problems.
- •2 Subjects who have clinical symptoms of dyspepsia, upper abdominal pain, heart burn, bloating, indigestion, flatulence, abdominal distension, belching and fullness after meal.
- •3 Subjects willing to give written informed consent.
- •4 Subjects who have not participated in similar kind of study in last 4 weeks.
Exclusion Criteria
- •1 Subjects with established hypertension, renal, hepatic or cardiac failure
- •2 Endocrine disorders
- •3 Use of prescription medication to treat gastric problems
- •4 Pregnant & lactating women.
- •5 Not willing to sign informed consent form.
Investigators
Similar Trials
Recruiting
Unknown
To evaluate the safety and efficacy of Plum serum in Hair GrowthCTRI/2024/02/062978Pureplay Skin Sciences India Pvt Ltd
Recruiting
Phase 4
Clinical study to evaluate the efficacy of a surgical procedure (Selective Laser Trabeculoplasty) in glaucoma patients in Indian population.CTRI/2022/07/044032Carl Zeiss India Bangalore Pvt Ltd
Completed
Phase 3
Safety and efficacy of Vamana(therapeutic emesis) and Virechana Karma(therapeutic purgation) after that Ksheera-Ghrita Rasayana in healthy individualsCTRI/2018/02/011876ational Institute of Ayurveda90
Completed
Not Applicable
Effect of baby productsCTRI/2022/04/041890Marico Limited37
Not yet recruiting
Phase 4
Management of oligozoospermia in AyurvedaCTRI/2024/07/070079Ayurvedic and Unani Tibbia College and Hospital